Liabilities / Assets
21st percentile
Higher debt load relative to assets than 21% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
21st percentile
Higher debt load relative to assets than 21% of similar nonprofits.
Liabilities / Revenue
13th percentile
Higher debt load relative to revenue than 13% of similar nonprofits.
Net Margin
95th percentile
Higher net margin than 95% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
99th percentile
Faster asset growth than 99% of similar nonprofits.
Revenue Growth
98th percentile
Faster revenue growth than 98% of similar nonprofits.
Assets
Up$6,297,217
Up $5,169,286 (+458%) from 2022
Net Assets
Up$6,208,929
Up $5,093,511 (+457%) from 2022
Liabilities
Up$88,288
Up $75,775 (+606%) from 2022
Revenue
Up$7,338,139
Up $5,534,349 (+307%) from 2022
Expenses
Up$2,307,855
Up $723,802 (+46%) from 2022
Net Income
Up$5,030,284
Up $4,810,547 (+2189%) from 2022
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Bioconnect iowa's mission is to make iowa a powerhouse of bioscience research and industry and to create exciting and high-paying careers for iowans whose work will improve the health and welfare of people around the globe.imagine an iowa where research and innovation lead to vaccines that prevent major diseases; environmentally friendly biobased products; medical devices that save countless lives; and precision and digital agriculture that transform food production.this is the future of bioscience in iowa, and the mission of bioconnect iowa is to make it happen.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.